Gnothisafton

INO is at a breaking point

Long
NASDAQ:INO   Inovio Pharmaceuticals, Inc.
Presented here are the three phases of INOs decline until the full exhaustion (psychological and ultimately financial)
of those who follow the stock and the sale of their shares with significant losses.

This must be a lesson for the thousands of new small investors who are trapped in the stock, not to hold a stock which breaks 30d SMA or 200d SMA.

On the other hand, some are making huge profits selling high (when we consider that the stock started rallying at $2.20 in October 2019)
and some other have huge profits sorting the stock.

Look at the MACD. It's like a cardiogram of someone who's slowly dying out. This probably means that INOs fall is in its final stage.

The stock is at a breaking point and must decide whether to move up or down. If it goes upward, the first resistance is at $10 and the next
more powerful resistance is at $13.80. If it goes downward there is a mid-term support from daily chart at $8.70 and next the long-term strong
support from monthly chart at $7.20.

It is very likely that the stock will first make a short misleading move either down or up the triangles resistances, and then move in the opposite direction.

Disclaimer
The writer of this text is not an investment advisor. The preceding content is intended to be used for informational and educational purposes only. It is not an advice or inducement for the purchase or sale of the products mentioned. Before making any investment based on your own personal circumstances, it is very important to do your own research and analysis and also take independent financial advice from a professional to verify any information provided here.
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.